Search results
May 31, 2024 · Michael Birnbaum is a national security reporter for The Washington Post, covering the State Department and diplomacy. He previously served more than a decade in Europe as The Post’s bureau ...
Michael obtained an A.B. in Chemical and Physical Biology at Harvard University in 2008. He then moved to Stanford University, where he completed his Ph.D. in Immunology in 2014. At Stanford, he worked in Professor K. Christopher Garcia’s laboratory, studying the molecular mechanisms of T cell receptor recognition, cross-reactivity, and ...
Deconstructing the peptide-MHC specificity of T cell recognition. ME Birnbaum, JL Mendoza, DK Sethi, S Dong, J Glanville, J Dobbins, ... Cell 157 (5), 1073-1087. , 2014. 597. 2014. Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer’s model.
Michael Birnbaum is an associate professor of biological engineering at MIT. He received his bachelor's degree in chemical and physical biology from Harvard University and his PhD from Stanford University. At Stanford, he worked under K. Christopher Garcia, and studied the molecular mechanisms of T cell receptor recognition, cross-reactivity ...
May 31, 2023 · WASHINGTON, DC - MAY 16: Michael Birnbaum, Staff climate and security reporter, Washington Post, in Washington, DC. (Bill O'Leary/The Washington Post) Announcement from National Editor Matea Gold ...
MIT professor Michael Birnbaum strives to prepare his students for success, from day one of graduate school through embarking on an enriching career path. For the thoughtfulness and depth of his feedback, the variety of different career paths he exposes students to, and his far-reaching inclusiveness within both his lab and his greater ...
People also ask
Who is Michael Birnbaum?
Who is Dr Birnbaum?
Who is Daniel Birnbaum?
Who is Nathan Birnbaum?
The Birnbaum Lab at MIT is a leading research laboratory specializing in the study of immune receptor recognition and function in cancer, autoimmunity, and infectious disease. We combine protein engineering, structural biology, and immunology to understand and then manipulate immune responses.
